Key Events This Week
30 Mar: Technical downturn signals bearish momentum
31 Mar: Rating upgraded to Sell on technical improvements
1 Apr: Stock price rises 2.42% amid positive market sentiment
2 Apr: Week closes at Rs.414.30, up 5.69% for the week
Apr 15
BSE+NSE Vol: 2.18 lacs

TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in price momentum and technical indicators, signalling a transition from a mildly bullish trend to a sideways movement. This change comes amid a decline in the stock price and a downgrade in its Mojo Grade, reflecting growing investor caution despite some positive returns over the past month.
Read full news article
TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip in the daily price, key technical indicators suggest improving market sentiment, offering a nuanced outlook for investors navigating this evolving landscape.
Read full news article
TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day gain of 1.38%, the stock’s technical indicators reveal a complex picture that investors should carefully analyse amid broader market volatility.
Read full news article
30 Mar: Technical downturn signals bearish momentum
31 Mar: Rating upgraded to Sell on technical improvements
1 Apr: Stock price rises 2.42% amid positive market sentiment
2 Apr: Week closes at Rs.414.30, up 5.69% for the week

TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 30 March 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in its financial and fundamental metrics. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends remain mixed, underscoring a cautious stance for investors.
Read full news article
TruAlt Bioenergy Ltd, a small-cap player in the commodity chemicals sector, has experienced a notable shift in its technical momentum, signalling a mild bearish trend after a period of sideways movement. The stock’s recent price action, combined with key technical indicators such as MACD, RSI, and moving averages, suggests increasing downside pressure, reflected in a 4.74% decline on 30 Mar 2026 and a downgrade to a Strong Sell rating by MarketsMOJO.
Read full news article
23 Mar: Intraday low amid price pressure; mild bullish technical signs
24 Mar: Downgrade to Strong Sell; technical downshift and 6.26% price drop
27 Mar: Intraday low and 7.29% decline; underperformance vs sector and Sensex
Weekly Summary: Stock closed at Rs.392.00, down 4.10%; Sensex down 1.46%

TruAlt Bioenergy Ltd experienced a significant intraday decline on 27 Mar 2026, touching a low of Rs 381.5, down 7.29% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and subdued market sentiment within the commodity chemicals space.
Read full news articlePlease find attached intimation.
Please find attached intimation regarding closure of Trading window.
Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available